 Acebutolol effects lipid profile erratum Am Cardiol Dec relation lipid profile incidence coronary artery disease results epidemiologic intervention studies antihypertensive agents beta blockers intrinsic sympathomimetic activity ISA negative effects lipids risk coronary artery disease ongoing Treatment Mild Hypertension Study third year patients date regard profile Additional end points multicenter double-blind study blood pressure reduction target organ deterioration trial patients nutritional behavioral counselling diet exercise habits alcohol sodium consumption hypertension nonpharmacologic means addition patients low doses classes antihypertensive medication acebutolol beta blocker ISA amlodipine calcium channel blocker chlorthalidone diuretic doxazosin alpha blocker angiotensin-converting enzyme inhibitor placebo year acebutolol significant decrease total cholesterol mg/dl placebo mg/dl chlorthalidone mg/dl significant decrease low-density lipoprotein cholesterol mg/dl placebo mg/dl chlorthalidone mg/dl change high-density lipoprotein cholesterol mg/dl